Accolade Accepts Strategic Venture Capital
Monday, July 20, 2015 5:32:00 AM PDT | VentureDeal
   Plymouth Meeting, Pennsylvania  --  Healthcare service technology company Accolade has received $22.5 million in strategic venture capital funding.

Accolade has developed a website and service that provides patients with a health assistant to help them with navigating the healthcare system.

Investors in the round included McKesson Ventures and Independence Health Group.

The company said it would enhance its analytics platform with the funding proceeds.

CEO Tom Spann was previously from the Health and Life Sciences practice at Accenture.